Ayurvedic management of Ringworm.

Efficacy of Sarjadi Lepa Gutika and Terbinafine Ointment in Dadru (Tinea Corporis)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029306

Enrollment

Registered

2020-11-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Sarjadi Lepa Gutika and Tiladi Churna: Sarjadi Lepa Gutika contains Chakramarda, Shastikshali, Haritaki, Sarjarasa will be given Quantity Sufficient Twice a Day for Local Application. T

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with cardinal features of Dadru (Kandu, Raaga, Mandala), The cases of Tinea corporis, Subjects having number of Mandala less than or equal to 9 and size of Mandala less than or equal to 9cm, Subjects willing to participate in the study and sign the consent form

Exclusion criteria

Exclusion criteria: Pregnant & lactating women, Chronicity more than 5 years of Dadru, Subjects suffering from Diabetes mellitus, Individuals having known allergy to Terbinafine, Cases of Tinea vesicolor, Tinea mannum, Tinea pedis, Tinea capitis, Tinea cruris

Design outcomes

Primary

Measure	Time frame
Relief from symptoms of Dadru i.e. Kandu, Raaga, Number and Size of MandalaTimepoint: 30 days	—

Secondary

Measure	Time frame
To check for reccurence after treatmentTimepoint: 45 days	—

Countries

India

Contacts

Public ContactShreyas Sachin Kulkarni

Datta Meghe Institute of Medical Sciences Demmed To Be University Wardha

dr.vinodade@gmail.com9689365368

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026